32
Active Trials
16
Phase 1
16
Phase 2
10
Phase 3
2
Therapeutic Areas
Portfolio Concentration: 153% of active trials in Oncology
Oncology
49 active / 94 total
Non-Hodgkin Lymphoma
15 active
6 Ph3
18 total since 2015
Solid Tumor (Advanced)
8 active
16 total since 2015
NSCLC
6 active
1 Ph3
10 total since 2015
Ovarian Cancer
4 active
2 Ph3
6 total since 2015
Endometrial Cancer
3 active
1 Ph3
7 total since 2015
Melanoma
2 active
3 total since 2015
Breast Cancer
2 active
2 total since 2015
Bladder Cancer
1 active
4 total since 2015
Triple Negative Breast Cancer
1 active
4 total since 2015
AML
1 active
2 total since 2015
CLL
1 active
2 total since 2015
Colorectal Cancer
1 active
2 total since 2015
Head and Neck Cancer
1 active
2 total since 2015
Pancreatic Cancer
1 active
2 total since 2015
MDS
1 active
1 total since 2015
Mesothelioma
1 active
1 total since 2015
Renal Cell Carcinoma
0 active
2 total since 2015
Hodgkin Lymphoma
0 active
2 total since 2015
Esophageal Cancer
0 active
2 total since 2015
Multiple Myeloma
0 active
1 total since 2015
Cervical Cancer
0 active
1 total since 2015
Thyroid Cancer
0 active
1 total since 2015
Sarcoma
0 active
1 total since 2015
Gastric Cancer
0 active
1 total since 2015
Prostate Cancer
0 active
1 total since 2015
Immunology
1 active / 2 total
Click an indication to see competitive landscape (all sponsors in that indication).
Data: ClinicalTrials.gov (2015+)